Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function

Summary

The purpose of this trial is to ascertain whether the withdrawal of calcineurin inhibitors (CNI) will lead to less kidney transplant damage when compared with minimisation. The investigators will assess this by comparing the degree of damage on kidney biopsies taken before and after minimisation/withdrawal of CNI.

Timeline

Start

2007-10

Primary completion

—

Completion

2010-02

Drugs

Indications